⚠ You're viewing a report from December 2023. Subscribe to get the latest →

FDA Enforcement — December 2023 Report

Automated analysis of 46 items from public government data sources. Updated daily.

Summary

46
Total items
26
High impact
20
Medium impact
0
Low impact

High-impact items this period

Woorilife & Health
Adulterated finished pharmaceuticals manufacturing non-compliance
Why: CGMP violations in pharmaceutical product manufacturing quality  ·  Dec 28  ·  Impact: HIGH
East Fork Cultivars
Unapproved new drug distributed and misbranded
Why: Selling unapproved botanical pharmaceutical products without FDA approval  ·  Dec 22  ·  Impact: HIGH
Wipro Unza Singapore Private, Limited
Refusal to provide records access to FDA inspectors
Why: Non-cooperation with regulatory inspection and document requests  ·  Dec 21  ·  Impact: HIGH
Curtis Jacquot dba Pacific BioLogic Co.
Dietary supplement CGMP violations and adulteration
Why: Non-compliance with current good manufacturing practices for dietary supplements  ·  Dec 21  ·  Impact: HIGH
Botanical Be
Unapproved new drug distributed and misbranded
Why: Marketing botanical products as drugs without FDA approval  ·  Dec 21  ·  Impact: HIGH
MiMedx Group, Inc.
HCT/P deviations from CFR regulations
Why: Non-compliance with human cells, tissues, and cellular products regulations  ·  Dec 20  ·  Impact: HIGH
Hua Da Trading, Inc.
Unapproved new drug distributed and misbranded
Why: Marketing pharmaceuticals without FDA approval and improper labeling  ·  Dec 20  ·  Impact: HIGH
Amazon.com, Inc.
Unapproved new drug marketplace distribution and misbranding
Why: Platform failed to prevent sale of non-approved pharmaceuticals  ·  Dec 20  ·  Impact: HIGH
Inopak, Ltd.
Adulterated finished pharmaceuticals manufacturing non-compliance
Why: CGMP violations in pharmaceutical manufacturing and quality systems  ·  Dec 15  ·  Impact: HIGH
Iowa Egg Company Inc.
Shell egg regulation violations producing adulterated product
Why: Failure to comply with PHS Act shell egg safety regulations  ·  Dec 15  ·  Impact: HIGH

Selected medium-impact items

My Vape Shack
Marketed adulterated and misbranded tobacco products violating FSPTCA
Why: Distributed unapproved tobacco vaping products without proper FDA compliance  ·  Dec 21  ·  Impact: MEDIUM
Vaproma Inc.
Marketed adulterated and misbranded tobacco products violating FSPTCA
Why: Distributed unapproved tobacco vaping products without proper FDA compliance  ·  Dec 20  ·  Impact: MEDIUM
Vape-X Club
Marketed adulterated and misbranded tobacco products violating FSPTCA
Why: Distributed unapproved tobacco vaping products without proper FDA compliance  ·  Dec 20  ·  Impact: MEDIUM
Samuel Rodriguez dba KiloKennelzz
Unapproved new animal drug distribution
Why: Marketing adulterated animal drugs without FDA approval  ·  Dec 20  ·  Impact: MEDIUM
Disposable Vapez
Marketed adulterated and misbranded tobacco products violating FSPTCA
Why: Distributed unapproved tobacco vaping products without proper FDA compliance  ·  Dec 20  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →